Drug Discovery Company Orbis Medicines Raises €90 Million in Series A Funding
Orbis Medicines, a Denmark-based oral macrocycle drug discovery company, raised €90 million in Series A funding. New Enterprise Associates (NEA) led the investment round with … Read more…